Abstract
The Antiplatelet Trialists' Collaboration provided convincing evidence of benefits of aspirin prophylaxis in patients after myocardial infarction,1 but many such patients do not receive it.2 3 Since most patients are...
Highlights
The Antiplatelet Trialists’ Collaboration provided convincing evidence of benefits of aspirin prophylaxis in patients after myocardial infarction,[1] but many such patients do not receive it.[2 3]
The health authority supplied data to the participating practices on currently registered patients who had been discharged after myocardial infarction over the past five years
A retrospective record review was carried out in general practice by the practice staff, who were asked to check the status of each patient relating to his or her eligibility for aspirin prophylaxis and any contraindications to aspirin
Summary
The Antiplatelet Trialists’ Collaboration provided convincing evidence of benefits of aspirin prophylaxis in patients after myocardial infarction,[1] but many such patients do not receive it.[2 3]. Aspirin prophylaxis in patients after myocardial infarction in 45 general practices in Leicestershire *All eligible patients were receiving aspirin in 12 practices. The health authority supplied data to the participating practices on currently registered patients who had been discharged after myocardial infarction over the past five years.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
